Pew-Stewart Scholars for Cancer Research
The Pew-Stewart Scholars for Cancer Research supports assistant professors of outstanding promise in science relevant to the advancement of a cure for cancer.
The award provides $240,000 in flexible support; $60,000 per year for a four-year period. One nomination will be invited from each of the participating institutions. Five Pew-Stewart Scholars for Cancer Research will be named during the current funding cycle.
- Nominees must have been awarded a doctorate in a field related to biomedical sciences or medicine.
- As of October 16, 2017, nominees must hold full-time appointments at the rank of assistant professor or the equivalent. (Appointments such as Research Assistant Professor, Adjunct Assistant Professor, Assistant Professor Research Track, Visiting Professor or Instructor are not eligible.)
- On June 30, 2017, candidates must have been in such an appointment for less than three years (not appointed before June 30, 2014), whether or not such an appointment was on a tenure track.
- Candidates may be nominated by their institution only twice. All applicants must be nominated by their institution and must complete the 2018 online application.
Letter of Intent
Letters of Intent are due Friday, June 2, 2017 via email to email@example.com. Letters of Intent should include the PI’s NIH Biosketch, a proposed title for the research project, and a 1-2 page abstract of the proposed research project. The selected investigator will be notified and invited to submit a full application by Winship.
Letter of Intent Deadline: 5:00 PM on Friday, June 2, 2017
Announcement of Nominee Selection: Friday, June 23, 2017
Application Deadline: Monday, October 16, 2017
Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery
The Behavioral Research Program, Epidemiology and Genomics Research Program, and Healthcare Delivery Research Program of the National Cancer Institute’s Division of Cancer Control and Population Sciences have collaborated on the release of a program announcement to study the utilization, adherence, and delivery of oral anticancer agents. Specifically, this program announcement encourages research grant applications to:
- Assess and describe the current state of oral anticancer medication utilization, delivery, and adherence;
- Identify structural, systemic, and psychosocial barriers to adherence; and
- Develop models and strategies to improve safe and effective delivery of these agents so that clinical outcomes are optimized.